Milan - Delayed Quote EUR

CVS HEALTH (1CVS.MI)

51.05

-0.40

(-0.78%)

At close: 11:35:56 AM GMT+1

After losing 22% in the past year, CVS Health Corporation (NYSE:CVS) institutional owners must be relieved by the recent gain

Key Insights Significantly high institutional ownership implies CVS Health's stock price is sensitive to their trading...

Simply Wall St. yesterday

CVS
CVS Health Foundation grants $4 million as part of its new healthy aging initiative

The CVS Health® Foundation (NYSE: CVS) today announced $4 million in grants over five years as part of its new Healthy Aging initiative to support Atlanta Regional Collaborative for Health Improvement in Atlanta, GA, Center for Better Aging in Chicago, IL, EngageWell Independent Provider Association in New York, NY and Palm Health Foundation in Boynton Beach, FL. Each organization will receive $1 million in funding to improve health care access and resources for aging community members with brai

PR Newswire 4 days ago

CVS
UnitedHealth’s Challenges With High Medical Costs Continue

The company’s shares fell in premarket trading following the healthcare firms first earnings since the killing of executive Brian Thompson.

The Wall Street Journal 11 days ago

UNH

ELV

HUM
Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says

The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.

The Wall Street Journal 12 days ago

UNH

CVS

CI
FTC alleges PBMs cost consumers $7.3 billion marking up drug prices

The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked the prices of specialty drugs to generate $7.3 billion in revenue from 2017 to 2022.

Yahoo Finance 12 days ago

CI

CVS

UNH
CVS Health to hold fourth quarter and full year 2024 earnings conference call

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results.

PR Newswire 14 days ago

CVS
CVS Health Insider Lowered Holding By 40% During Last Year

Viewing insider transactions for CVS Health Corporation's ( NYSE:CVS ) over the last year, we see that insiders were...

Simply Wall St. 15 days ago

CVS
CVS Health supporting customers, patients, members and colleagues amid California wildfires

CVS Health® (NYSE: CVS) is actively supporting its customers, members, provider partners and colleagues as they respond to the California wildfires. The company prioritizes the health and safety of impacted communities and is dedicated to providing access to the products and services they need.

PR Newswire 16 days ago

CVS
CVS Health price target lowered to $60 from $67 at Truist

Truist analyst David MacDonald lowered the firm’s price target on CVS Health (CVS) to $60 from $67 and keeps a Buy rating on the shares as part of a broader research note previewing 2025 for Healthcare Services. The firm sees the outlook for the group as “mixed”, with bullish stance on the underlying demand drivers and overarching sector tailwinds that include demographics, value-based care, and core demand being offset by heightened concern around a likely more cost focused government backdrop.

TipRanks 20 days ago

CVS
CVS Pharmacy achieves CVS CostVantage milestone

Delivering on the promise of a simpler, more transparent, and more sustainable approach to retail pharmacy services, CVS Health® (NYSE: CVS) today announced that all of the commercial prescriptions dispensed through CVS Pharmacy® are contracted through the company's innovative CVS CostVantage reimbursement model starting this year.

PR Newswire 21 days ago

CVS
Healthcare Stocks Are Down and Out. Opportunities Abound.

Donald Trump’s election win prompted even more bullishness in a stock market that was already up significantly for the year. For healthcare investors, though, it represented yet another reason to dump some stock. Trump’s appointment of industry skeptics like Robert F. Kennedy Jr., alongside broader expectations of a Republican crackdown on programs like Medicaid and Obamacare, has prompted a selloff in everything from hospitals to pharmaceuticals, health insurers and biotech.

The Wall Street Journal 21 days ago

PFE

ISRG

LLY
CVS Health announces quarterly dividend

CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation. The dividend is payable on February 3, 2025, to holders of record on January 23, 2025.

PR Newswire 24 days ago

CVS
Drug Middlemen Spared by Trump and Musk, for Now

Tucked into the bipartisan budget deal that President-elect Donald Trump’s allies torpedoed earlier this month was a rare and significant attempt to reform the mechanics of America’s drug-pricing system. Americans are broadly aware of how big pharma profits from high drug prices, but few understand the market distortions introduced by pharmacy benefit management (PBM) companies that negotiate prices on behalf of employers, insurers and government programs.

The Wall Street Journal 28 days ago

CI

LLY

CVS
UnitedHealth’s Army of Doctors Helped It Collect Billions More From Medicare

The biggest Medicare Advantage insurer presented physicians with checklists of potential diagnose.; “I didn’t think I was obese,” one suspicious patient told his doctor.

The Wall Street Journal 28 days ago

CVS

UNH

HUM
Is CVS Health (NYSE:CVS) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Simply Wall St. 30 days ago

CVS
The Celebrity Activist Investor Is Going Extinct

An era of big-name activists with fiery personalities waging noisy proxy battles and wielding brash tactics to win board seats is over. Carl Icahn, facing attacks on how he manages his own publicly traded firm, has slowed his fire. Nelson Peltz, fresh off losing a battle with Disney is planning to hand his firm to his less pugnacious son and others.

The Wall Street Journal last month

INTC

UA

UAA
Healthcare: Why the sector underperformed in 2024

The healthcare sector (XLV) faced significant challenges in the markets throughout 2024, becoming the worst-performing S&P 500 (^GSPC) sector of the year. Yahoo Finance Senior Health Reporter Anjalee Khemlani analyzes the key market themes that influenced the sector this year and examines investor sentiment heading into 2025 — with a detailed look at leading stocks across pharmaceutical, biotechnology, and other healthcare segments. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Angel Smith

Yahoo Finance Video last month

CVS

ISRG

LLY
There's uncertainty ahead for the health insurance industry in 2025

Health insurers faced a tough year, with some faring worse than others. How the upcoming year, and the Trump 2.0 presidency, will impact the stocks remains unclear.

Yahoo Finance last month

CVS

UNH

ELV
3 biggest catalysts expected for healthcare in 2025

After an eventful year in the pharmaceutical and biotech industries, what lies ahead for the health landscape in 2025? Yahoo Finance senior health reporter Anjalee Khemlani outlines the three biggest catalysts for change and innovation for healthcare in the new year, including GLP-1 weight-loss drugs and proposed regulations on pharmacy benefit managers (PBMs) from the second Trump administration. To watch more expert insights and analysis on the latest market action, check out more Catalysts here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video last month

NONOF

NVO

LLY
The healthcare 'barriers' that made this fmr. insurance exec. walk away

It has been nearly three weeks since UnitedHealthcare (UNH) CEO Brian Thompson was shot and killed in New York City. The suspected gunman, Luigi Mangione, has been charged with several counts of murder and even terrorism, which he pleaded not guilty to on Monday. In the aftermath of this event, Americans have expressed an outcry over their frustrations with dealing with health insurance providers and maneuvering the cracks in the US healthcare system. Center for Health and Democracy (CHD) President Wendell Potter joins Market Domination's Josh Lipton and Yahoo Finance senior health reporter Anjalee Khemlani to speak more about his self-described "crisis of conscience" when he worked within the health industry. Potter penned a New York Times op-ed piece last week titled I Was a Health Insurance Executive. What I Saw Made Me Quit. "I became aware of the barriers that health insurance companies have put in place to assure their profitability, but that have resulted in more and more Americans not being able to get the care that they need, medically necessary care, even with insurance," the former Cigna (CI) vice president of communications explains. "Those barriers that that they put in place to assure profitability and shareholder return really made me walk away. I used to handle financial communications for Cigna, my name was on all of the company's quarterly reports for ten years. So I saw how the company made money, where it came from, what they did with it, but also the way that they were able to earn the profits..." Potter weighs in on the performance of major health insurance stocks in 2024 and how US policymakers are expected to act to better regulate the industry. Follow Yahoo Finance's coverage of the incident and the outpouring of Americans' commentary on the US healthcare system: Bipartisan lawmakers appear 'aligned' on PBM, insurance reformHealthcare concerns rise as insurers deny patient claimsLuigi Mangione pleads not guilty in UnitedHealthcare CEO killingUnitedHealth Group CEO calls healthcare system 'flawed' in NYT letterHealth insurance industry 'laying low' in aftermath of UnitedHealthcare CEO shootingUS has a 'sickcare system,' not a healthcare system: Anomaly CEOHow to fix the health insurance industry everybody seems to hateUnitedHealthcare exec shooting is 'a wake-up call for the industry': Oscar Health CEOUS healthcare industry 'is now broken,' Oscar Health CEO explains To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video last month

HUM

OSCR

UNH

Performance Overview

Return	1CVS.MI	S&P 500
YTD	+22.00%	+1.44%
1-Year	-22.28%	+22.52%
3-Year	-19.56%	+37.76%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

CVS HEALTH (1CVS.MI)

After losing 22% in the past year, CVS Health Corporation (NYSE:CVS) institutional owners must be relieved by the recent gain

CVS Health Foundation grants $4 million as part of its new healthy aging initiative

UnitedHealth’s Challenges With High Medical Costs Continue

Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says

FTC alleges PBMs cost consumers $7.3 billion marking up drug prices

CVS Health to hold fourth quarter and full year 2024 earnings conference call

CVS Health Insider Lowered Holding By 40% During Last Year

CVS Health supporting customers, patients, members and colleagues amid California wildfires

CVS Health price target lowered to $60 from $67 at Truist

CVS Pharmacy achieves CVS CostVantage milestone

Healthcare Stocks Are Down and Out. Opportunities Abound.

CVS Health announces quarterly dividend

Drug Middlemen Spared by Trump and Musk, for Now

UnitedHealth’s Army of Doctors Helped It Collect Billions More From Medicare

Is CVS Health (NYSE:CVS) A Risky Investment?

The Celebrity Activist Investor Is Going Extinct

Healthcare: Why the sector underperformed in 2024

There's uncertainty ahead for the health insurance industry in 2025

3 biggest catalysts expected for healthcare in 2025

The healthcare 'barriers' that made this fmr. insurance exec. walk away

Performance Overview